Use of the TLR2 ligand polysaccharide krestin to maximize conventional cancer therapy. Issue 3 (4th May 2017)

Record Type:: Journal Article
Title:: Use of the TLR2 ligand polysaccharide krestin to maximize conventional cancer therapy. Issue 3 (4th May 2017)
Main Title:: Use of the TLR2 ligand polysaccharide krestin to maximize conventional cancer therapy
Authors:: Gwin, William R.
Standish, Leanna J.
Disis, Mary L.
Abstract:
Is Part Of:: Expert review of quality of life in cancer care. Volume 2:Issue 3(2017)
Journal:: Expert review of quality of life in cancer care
Issue:: Volume 2:Issue 3(2017)
Issue Display:: Volume 2, Issue 3 (2017)
Year:: 2017
Volume:: 2
Issue:: 3
Issue Sort Value:: 2017-0002-0003-0000
Page Start:: 133
Page End:: 135
Publication Date:: 2017-05-04
Subjects:: HER2 -- polysaccharide kinase -- toll-like receptors -- natural killer cells -- CD8+ -- T cells
Cancer -- Patients -- Care -- Periodicals
Cancer -- Treatment -- Periodicals
Cancer -- Palliative treatment -- Periodicals
616.99406
Journal URLs:: http://www.tandfonline.com/ ↗
DOI:: 10.1080/23809000.2017.1324300 ↗
Languages:: English
ISSNs:: 2380-9000
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 1336.xml